Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Average Recommendation of Moderate Buy by Analysts

Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year […]

Related Keywords

United States ,Patricia Carr ,Philipl Johnson ,Piper Sandler ,Stifel Nicolaus ,Jazz Pharmaceuticals ,Jazz Pharmaceuticals Company Profile ,Rise Advisors ,Covestor Ltd ,Securities Exchange Commission ,Nasdaq ,Assetmark Inc ,Cape Investment Advisory Inc ,Barclays ,Jazz Pharmaceuticals Price Performance ,Analyst Recommendations For Jazz Pharmaceuticals ,News Ratings For Jazz Pharmaceuticals Daily ,Get Free Report ,Exchange Commission ,Investment Advisory ,Spire Wealth Management ,Wealth Management ,Get Free ,Jazz Pharmaceuticals Daily ,